Skip to main content

Paragon Associates & Paragon Associates Ii Joint Venture

Source: SEC Form 13F · as of Mar 2026

Paragon Associates & Paragon Associates Ii Joint Venture holds 2 biotech & pharma companies tracked by BioSniper, totaling $7.7M in value as of Mar 2026 (SEC Form 13F).

Companies held

2

Total value held

$7.7M

BioSniper AIPage evidence connected

Prepared research question

What matters most for DiaMedica Therapeutics Inc. (DMAC)—catalysts, financial risk and supporting evidence?

Run cited research

Traceable citations · Unknowns marked

CompanySharesValue
DMACDiaMedica Therapeutics Inc.875,000$5.9M
PROFProfound Medical Corp.276,001$1.8M

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.